Molecular Biology Enzymes and Kits & Reagents

Molecular Biology Enzymes and Kits & Reagents

Global Molecular Biology Enzymes and Kits & Reagents Market to Reach US$70.5 Billion by 2030

The global market for Molecular Biology Enzymes and Kits & Reagents estimated at US$28.5 Billion in the year 2023, is expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.8% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$64.8 Billion by the end of the analysis period. Growth in the Enzymes segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.8 Billion While China is Forecast to Grow at 13.2% CAGR

The Molecular Biology Enzymes and Kits & Reagents market in the U.S. is estimated at US$7.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.8 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Molecular Biology Enzymes and Kits & Reagents Market - Key Trends and Drivers Summarized

How Are Molecular Biology Enzymes, Kits & Reagents Revolutionizing Research?

Molecular biology enzymes, kits, and reagents are essential tools used in various research applications, including DNA sequencing, polymerase chain reactions (PCR), gene cloning, and protein analysis. These products play a critical role in life sciences, biotechnology, and pharmaceutical research, enabling scientists to study the structure, function, and interactions of genetic material. Molecular biology enzymes, such as DNA polymerases, restriction enzymes, and ligases, facilitate the manipulation and analysis of nucleic acids, which is crucial for understanding diseases, developing new treatments, and advancing genetic engineering. The market for molecular biology enzymes, kits, and reagents is expanding due to increasing research activities in genomics, proteomics, and personalized medicine. With the growing focus on understanding genetic disorders and developing targeted therapies, there is a rising demand for advanced molecular biology tools. Pharmaceutical companies and research institutions are investing heavily in molecular biology research to accelerate drug discovery and improve diagnostic techniques, further fueling the market`s growth.

What Trends Are Driving the Molecular Biology Enzymes, Kits & Reagents Market?

Key trends influencing the molecular biology enzymes, kits, and reagents market include the rise of next-generation sequencing (NGS), the growth of biotechnology and life sciences research, and the increasing focus on personalized medicine. NGS technologies have revolutionized genomics research by enabling high-throughput analysis of DNA sequences, driving the demand for molecular biology enzymes and reagents. The rapid advancements in NGS platforms and techniques are creating opportunities for companies to develop specialized enzymes and kits tailored for sequencing applications. The growing emphasis on personalized medicine, which involves tailoring medical treatments based on an individual`s genetic makeup, is also boosting the demand for molecular biology tools. Researchers are using these tools to study genetic variations and develop precision therapies. Additionally, the expansion of the biotechnology industry, with increased funding for research and development, is further contributing to market growth by driving demand for high-quality molecular biology products.

How Do Market Segments Impact Molecular Biology Enzymes, Kits & Reagents?

Product categories include enzymes, kits, and reagents, with enzymes accounting for the largest share due to their extensive use in various molecular biology techniques. Applications of these products span across research, diagnostics, and therapeutic development, with research laboratories and academic institutions being the primary users. The end-user segment includes academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology segment is witnessing significant growth due to increasing investments in drug discovery and development. Geographically, North America dominates the market due to advanced research infrastructure and substantial funding for life sciences. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increasing research activities and government support for biotechnology development.

What Factors Are Driving the Growth in the Molecular Biology Enzymes, Kits & Reagents Market?

The growth in the molecular biology enzymes, kits, and reagents market is driven by several factors, including the rising demand for genetic research, advancements in molecular biology techniques, and the increasing focus on personalized medicine. The expansion of genomics and proteomics research is boosting the demand for molecular biology tools. Advancements in NGS and other molecular techniques are creating opportunities for the development of specialized products. Furthermore, the growing trend of precision medicine is encouraging the use of molecular biology enzymes, kits, and reagents for the development of targeted therapies and diagnostics.

Select Competitors (Total 33 Featured) -
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Molecular Biology Enzymes and Kits & Reagents – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Genomics and Proteomics Research Spurs Growth in Molecular Biology Enzymes and Kits & Reagents Market
Technological Advancements in High-Fidelity Enzymes and PCR Kits Strengthen Business Case for Adoption
Growing Focus on Personalized Medicine and Diagnostic Applications Expands Addressable Market
Expansion of Molecular Biology Enzymes and Kits in Pharmaceutical and Biotechnology Industries Fuels Market Growth
Increasing Adoption of NGS (Next-Generation Sequencing) and CRISPR Technologies Expands Market Opportunities
Technological Innovations in Recombinant Enzymes and High-Throughput Kits Propel Market Expansion
Rising Focus on Enhancing Accuracy and Reproducibility in Molecular Experiments Drives Demand for Enzymes and Kits
Growing Use of Molecular Biology Enzymes and Kits in Agriculture and Food Safety Testing Expands Market Potential
Focus on Reducing Experiment Time and Improving Workflow Efficiency Strengthens Market for Molecular Biology Reagents
Rising Adoption of Molecular Biology Enzymes in Cancer Research and Biomarker Discovery Expands Addressable Market
Technological Advancements in Point-of-Care Molecular Diagnostic Kits Propel Market Growth
Expansion of Molecular Biology Reagents in Environmental and Microbial Studies Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Academic & Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Hospital & Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 37: World Molecular Biology Enzymes and Kits & Reagents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
CHINA
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Europe 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Asia-Pacific 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Asia-Pacific 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of World 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2014, 2024 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of World 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2014, 2024 & 2030
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of World 16-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings